Related Experiment Videos
Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial
N Yuksel1, S R Majumdar, C Biggs
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 3126 Dentistry/Pharmacy Centre, Edmonton, AB, T6G 2N8, Canada. nyuksel@pharmacy.ualberta.ca
Summary
Community pharmacist screening programs effectively doubled osteoporosis testing and treatment rates. However, further interventions are needed as many eligible patients still did not receive appropriate care.
Area of Science:
- Pharmacology and Pharmaceutical Sciences
- Public Health and Epidemiology
Background:
- Osteoporosis screening and treatment rates are suboptimal in many populations.
- Community pharmacists are accessible healthcare providers who can play a role in improving osteoporosis care.
Purpose of the Study:
- To evaluate the impact of a community pharmacist-led screening and education intervention on osteoporosis testing and treatment.
- To assess the effectiveness of a multifaceted intervention in increasing bone mineral density (BMD) testing or osteoporosis medication prescriptions.
Main Methods:
- A randomized controlled trial involving 262 patients meeting BMD testing guidelines.
- Intervention group received printed materials, education, and quantitative ultrasound, while the control group did not.
- Primary outcome was a composite of BMD testing or osteoporosis medication prescription within 4 months.
Main Results:
- The intervention group showed a significantly higher rate of achieving the primary endpoint (22% vs. 11%, RR 2.1).
- This increase was primarily driven by a higher rate of BMD testing in the intervention group (22% vs. 10%).
- Calcium intake also increased significantly more in the intervention group.
Conclusions:
- A community pharmacist screening program can effectively double osteoporosis testing rates.
- Despite the intervention's success, a significant number of eligible patients did not receive appropriate care, indicating a need for more intensive strategies.
- Pharmacist-led interventions show promise in improving osteoporosis management within community settings.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...